Cargando…
Novel Galiellalactone Analogues Can Target STAT3 Phosphorylation and Cause Apoptosis in Triple-Negative Breast Cancer
Aberrant activation of signal transducer and activator of transcription 3 (STAT3) has been documented in various malignancies including triple-negative breast cancers (TNBCs). The STAT3 transcription factor can regulate the different important hallmarks of tumor cells, and thus, targeting it can be...
Autores principales: | Ko, Hyejin, Lee, Jong Hyun, Kim, Hyun Su, Kim, Taewoo, Han, Young Taek, Suh, Young-Ger, Chun, Jaemoo, Kim, Yeong Shik, Ahn, Kwang Seok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571922/ https://www.ncbi.nlm.nih.gov/pubmed/31058868 http://dx.doi.org/10.3390/biom9050170 |
Ejemplares similares
-
Structural Congeners of Izenamides Responsible for Cathepsin D Inhibition: Insights from Synthesis-Derived Elucidation †
por: Kim, Hyun Su, et al.
Publicado: (2023) -
Galiellalactone inhibits the STAT3/AR signaling axis and suppresses Enzalutamide-resistant Prostate Cancer
por: Thaper, Daksh, et al.
Publicado: (2018) -
STAT3 inhibition with galiellalactone effectively targets the prostate cancer stem-like cell population
por: Canesin, Giacomo, et al.
Publicado: (2020) -
The STAT3 inhibitor galiellalactone inhibits the generation of MDSC‐like monocytes by prostate cancer cells and decreases immunosuppressive and tumorigenic factors
por: Hellsten, Rebecka, et al.
Publicado: (2019) -
Galiellalactone Inhibits Stem Cell-Like ALDH-Positive Prostate Cancer Cells
por: Hellsten, Rebecka, et al.
Publicado: (2011)